KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Buildings (2016 - 2025)

Merck has reported Buildings over the past 17 years, most recently at $18.0 billion for Q4 2025.

  • Quarterly Buildings rose 9.92% to $18.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 billion through Dec 2025, up 9.92% year-over-year, with the annual reading at $18.0 billion for FY2025, 9.92% up from the prior year.
  • Buildings was $18.0 billion for Q4 2025 at Merck, up from $16.4 billion in the prior quarter.
  • Over five years, Buildings peaked at $18.0 billion in Q4 2025 and troughed at $12.5 billion in Q4 2021.
  • The 5-year median for Buildings is $15.0 billion (2023), against an average of $15.0 billion.
  • Year-over-year, Buildings increased 4.43% in 2021 and then increased 13.67% in 2023.
  • A 5-year view of Buildings shows it stood at $12.5 billion in 2021, then increased by 5.08% to $13.2 billion in 2022, then rose by 13.67% to $15.0 billion in 2023, then rose by 9.31% to $16.4 billion in 2024, then rose by 9.92% to $18.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Buildings are $18.0 billion (Q4 2025), $16.4 billion (Q4 2024), and $15.0 billion (Q4 2023).